This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,371.87, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen, a for-profit corporate entity registered in the System for Award Management (SAM.gov), holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was not designated with a set-aside requirement, indicating open competition.
Generated 2/13/25, 9:25 AM